Balance between proinflammatory cytokines and their inhibitors in bronchial lavage from patients with status asthmaticus - PubMed (original) (raw)
Comparative Study
Balance between proinflammatory cytokines and their inhibitors in bronchial lavage from patients with status asthmaticus
I Tillie-Leblond et al. Am J Respir Crit Care Med. 1999 Feb.
Abstract
Status asthmaticus (SA) is an acute respiratory failure combining an acute bronchospastic reaction with a severe airway inflammation. We previously reported an important influx of neutrophils and an increased secretion of interleukin-8 (IL-8) in patients with SA. The aim of this prospective study was to evaluate in bronchial lavage (BL) of patients with SA (n = 9) under mechanical ventilation (MV) the concentrations of cytokines and related mediators which have the ability to modulate inflammation, either proinflammatory (interleukin-1beta [IL-1beta], IL-6, tumor necrosis factor-alpha [TNF-alpha]), or anti-inflammatory mediators (IL-10, transforming growth factor-beta1 [TGF-beta1]), interleukin-1 receptor antagonist [IL-1Ra], soluble TNF receptor I and II [sTNFRI and II]). To determine the relative importance of both pro- and anti-inflammatory mediators, the net inflammatory activity was analyzed by the capacity of BL fluids (BLF) to increase intercellular adhesion molecule-1 (ICAM-1) expression in the human lung A549 epithelial cell line. These data were compared with those obtained from patients who required MV without respiratory disease (V, n = 4), controlled asthma (A, n = 11), and nonsmoking healthy volunteers (C, n = 8). Levels of IL-1, IL-6, TNF-alpha, and of the active form of TGF-beta1 were significantly higher in SA compared with the other groups. The concentrations of IL-1Ra, IL-10, the latent form of TGF-beta1, and of the sTNFRI and II were not significantly different between SA and V, albeit higher in SA than in A and C. The ratio between IL-1Ra and IL-1beta was significantly higher in patients with SA compared with the other groups, whereas there was no difference for the ratio between both types of sTNFR and TNF-alpha. Despite a marked increase of anti-inflammatory mediators in BL from patients with SA, the net inflammatory activity was found to be proinflammatory and mainly due to the presence of bioactive IL-1beta (79% inhibition of ICAM-1 expression with anti-IL-1beta antibodies) and to a lesser extent TNF-alpha (32% inhibition with anti-TNF-alpha antibodies).
Similar articles
- CC chemokines and interleukin-5 in bronchial lavage fluid from patients with status asthmaticus. Potential implication in eosinophil recruitment.
Tillie-Leblond I, Hammad H, Desurmont S, Pugin J, Wallaert B, Tonnel AB, Gosset P. Tillie-Leblond I, et al. Am J Respir Crit Care Med. 2000 Aug;162(2 Pt 1):586-92. doi: 10.1164/ajrccm.162.2.9907014. Am J Respir Crit Care Med. 2000. PMID: 10934091 - Soluble TNF-alpha receptor and IL-1 receptor antagonist elevation in BAL in active pulmonary TB.
Tsao TC, Li L, Hsieh M, Liao S, Chang KS. Tsao TC, et al. Eur Respir J. 1999 Sep;14(3):490-5. doi: 10.1034/j.1399-3003.1999.14c03.x. Eur Respir J. 1999. PMID: 10543265 - Cytokines and soluble cytokine receptors in pleural effusions from septic and nonseptic patients.
Marie C, Losser MR, Fitting C, Kermarrec N, Payen D, Cavaillon JM. Marie C, et al. Am J Respir Crit Care Med. 1997 Nov;156(5):1515-22. doi: 10.1164/ajrccm.156.5.9702108. Am J Respir Crit Care Med. 1997. PMID: 9372669 - Kinetics of tumour necrosis factor-alpha, soluble tumour necrosis factor receptors, interleukin 1-beta and its receptor antagonist during serious infections.
van Deuren M. van Deuren M. Eur J Clin Microbiol Infect Dis. 1994;13 Suppl 1:S12-6. doi: 10.1007/BF02390680. Eur J Clin Microbiol Infect Dis. 1994. PMID: 7821299 Review. - Cytokine inhibitors in autoimmune disease.
Weckmann AL, Alcocer-Varela J. Weckmann AL, et al. Semin Arthritis Rheum. 1996 Oct;26(2):539-57. doi: 10.1016/s0049-0172(96)80042-4. Semin Arthritis Rheum. 1996. PMID: 8916298 Review.
Cited by
- Multi-walled carbon nanotube length as a critical determinant of bioreactivity with primary human pulmonary alveolar cells.
Sweeney S, Berhanu D, Misra SK, Thorley AJ, Valsami-Jones E, Tetley TD. Sweeney S, et al. Carbon N Y. 2014 Nov 1;78:26-37. doi: 10.1016/j.carbon.2014.06.033. Carbon N Y. 2014. PMID: 25780270 Free PMC article. - Influenza enhances caspase-1 in bronchial epithelial cells from asthmatic volunteers and is associated with pathogenesis.
Bauer RN, Brighton LE, Mueller L, Xiang Z, Rager JE, Fry RC, Peden DB, Jaspers I. Bauer RN, et al. J Allergy Clin Immunol. 2012 Oct;130(4):958-67.e14. doi: 10.1016/j.jaci.2012.07.013. J Allergy Clin Immunol. 2012. PMID: 23021143 Free PMC article. - Interleukin-6 as a biomarker for asthma: hype or is there something else?
Poynter ME, Irvin CG. Poynter ME, et al. Eur Respir J. 2016 Oct;48(4):979-981. doi: 10.1183/13993003.01597-2016. Eur Respir J. 2016. PMID: 27694408 Free PMC article. No abstract available. - Quercetin blocks airway epithelial cell chemokine expression.
Nanua S, Zick SM, Andrade JE, Sajjan US, Burgess JR, Lukacs NW, Hershenson MB. Nanua S, et al. Am J Respir Cell Mol Biol. 2006 Nov;35(5):602-10. doi: 10.1165/rcmb.2006-0149OC. Epub 2006 Jun 22. Am J Respir Cell Mol Biol. 2006. PMID: 16794257 Free PMC article. - IL-10 is necessary for the expression of airway hyperresponsiveness but not pulmonary inflammation after allergic sensitization.
Mäkelä MJ, Kanehiro A, Borish L, Dakhama A, Loader J, Joetham A, Xing Z, Jordana M, Larsen GL, Gelfand EW. Mäkelä MJ, et al. Proc Natl Acad Sci U S A. 2000 May 23;97(11):6007-12. doi: 10.1073/pnas.100118997. Proc Natl Acad Sci U S A. 2000. PMID: 10811896 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous